NextGen Healthcare Announces No Fee Version of NDSC’s CareSelect™ Imaging Through NextGen® Ambulatory EHR
February 20 2017 - 8:00AM
Business Wire
Ensuring transparent education and intervention
at the point of care
NextGen Healthcare Information Systems, LLC, a wholly owned
subsidiary of Quality Systems, Inc. (NASDAQ:QSII) today proudly
announced its agreement with National Decision Support Company
(NDSC) to deliver a no fee version of its CareSelectTM Imaging
solution, known as ACR Select™ Basic, to enable compliance with the
requirements of the Protecting Access to Medicare Act of 2014
(PAMA), its associated AUC consultation requirements, and enable
value-based imaging.
NextGen Healthcare selected ACR Select Basic as its exclusive
solution to enable compliance for PAMA. “We are delighted to
partner with National Decision Support Company, the leading trusted
decision support partner, for compliance with PAMA,” said Justin
Elliot, Senior Director of Product Management for NextGen
Healthcare.
The no fee ACR Select Basic solution allows caregivers to
consult Appropriate Use Criteria (AUC) in their native EMR workflow
when ordering Medicare advanced imaging services. The result of
this partnership is the robust capability to deliver a
comprehensive set of structured indications and AUC from multiple
qualified provider-led entities, including the American College of
Radiology, into a single delivery platform. This enables full
compliance with all aspects of PAMA for caregivers who order
Medicare advanced imaging services. The partnership places end
users at the forefront of compliance and quality through complete
coverage and ensures that providers find the correct clinical test
for every advanced imaging exam. Availability at the point of care
ensures that the order generated results in a payable claim. It
also provides a rich educational tool for caregivers and
patients.
“Today, Healthcare organizations are investing in the
appropriate reporting tools in time for the January 1, 2018
deadline specified by CMS,” said Elliot. Through collaborative
agreements and partnerships, NextGen Healthcare is committed to
providing actionable data at the point of care for informed
clinical decisions.
About National Decision Support Company
The National Decision Support Company provides enterprise-wide
Clinical Decision Support solutions that enable more efficient and
appropriate care, improve population health, and save money. Our
CareSelect Imaging technology platform converts published
guidelines from credible, compliant content sources into actionable
decision support criteria delivered directly into the EMR
workflow.
About ACR Select™ Basic
ACR Select Basic provides direct integration of imaging decision
support into Ambulatory EHRs to deliver a comprehensive range of
Appropriate Use Criteria for diagnostic imaging. AUC is sourced
from qualified Provider Led Entities (qPLE) including the American
College of Radiology. Criteria is delivered directly into the EHR
workflow to provide actionable, PAMA compliant decision support in
real time.
About NextGen Healthcare
NextGen Healthcare, a wholly owned subsidiary of Quality
Systems, Inc., helps ambulatory care organizations succeed in
value-based care by empowering them to nurture measurably healthier
patients and communities at a lower cost. It does this with deep
clinical, financial, operational, and regulatory expertise, using
consulting and educational services coupled with a robust
technology portfolio of flexible, scalable, and cost-effective
ambulatory solutions; including a certified EHR, practice
management, interoperability, care management, patient engagement
and population health management, analytics, e-transaction, and
revenue cycle management solutions. For more information, visit
www.nextgen.com. Follow NextGen Healthcare on Twitter, Facebook, or
LinkedIn.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within
the meaning of the federal securities laws, including but not
limited to, statements regarding future events, developments in the
healthcare sector and regulatory framework, the Company's future
performance, as well as management's expectations, beliefs,
intentions, plans, estimates or projections relating to the future
(including, without limitation, statements concerning revenue, net
income, and earnings per share). Risks and uncertainties exist that
may cause the results to differ materially from those set forth in
these forward-looking statements. Factors that could cause the
anticipated results to differ from those described in the
forward-looking statements and additional risks and uncertainties
are set forth in Part I, Item A of our most recent Annual Report on
Form 10-K for the fiscal year ended March 31, 2016 and subsequently
filed Quarterly Reports on Form 10-Q, including but not limited to:
the volume and timing of systems sales and installations; length of
sales cycles and the installation process; the possibility that
products will not achieve or sustain market acceptance; seasonal
patterns of sales and customer buying behavior; impact of incentive
payments under The American Recovery and Reinvestment Act on sales
and the ability of the Company to meet continued certification
requirements; the development by service introductions, development
and product upgrade releases; undetected errors or bugs in
software; product liability; changing economic, political or
regulatory influences in the health-care industry; changes in
product-pricing policies; availability of third-party products and
components; competitive pressures including product offerings,
pricing and promotional activities; the Company's ability or
inability to attract and retain qualified personnel; possible
regulation of the Company's software by the U.S. Food and Drug
Administration; changes of accounting estimates and assumptions
used to prepare the prior periods' financial statements;
disruptions caused by acquisitions of companies, products, or
technologies; and general economic conditions. A significant
portion of the Company's quarterly sales of software product
licenses and computer hardware is concluded in the last month of a
fiscal quarter, generally with a concentration of such revenues
earned in the final ten business days of that month. Due to these
and other factors, the Company's revenues and operating results are
very difficult to forecast. A major portion of the Company's costs
and expenses, such as personnel and facilities, are of a fixed
nature and, accordingly, a shortfall or decline in quarterly and/or
annual revenues typically results in lower profitability or losses.
As a result, comparison of the Company's period-to-period financial
performance is not necessarily meaningful and should not be relied
upon as an indicator of future performance. These forward-looking
statements speak only as of the date hereof. The Company undertakes
no obligation to publicly update any forward-looking statements,
whether as a result of new information, future events or
otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170220005131/en/
NextGen HealthcareShannan Bieler,
215-657-7010sebieler@nextgen.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Sep 2023 to Sep 2024